NEW ORLEANS — In a pivotal appointment for the future of reconstructive medicine, Babak J. Mehrara, MD, has officially assumed the presidency of The Plastic Surgery Foundation (The PSF). The announcement, made during the American Society of Plastic Surgeons’ (ASPS) annual scientific conference, Plastic Surgery The Meeting, marks the beginning of a one-year tenure that promises to bridge the gap between bench-side research and bedside patient care.
Dr. Mehrara, a preeminent figure in oncologic reconstruction and lymphatic research, takes the helm at a time when the field of plastic surgery is undergoing a rapid evolution—driven by technological integration, a deeper understanding of molecular biology, and a renewed focus on global health equity.
Main Facts: A New Chapter for The PSF
The Plastic Surgery Foundation serves as the philanthropic and research engine of the American Society of Plastic Surgeons. Its mission is to support the research, development, and international humanitarian activities that define the next generation of surgical standards.
Dr. Mehrara’s appointment, confirmed on October 12, 2025, positions him at the intersection of clinical excellence and academic inquiry. As President, he is tasked with steering the organization’s strategic initiatives, which include funding innovative pilot studies, fostering education for early-career surgeons, and expanding the reach of reconstructive procedures in underserved populations.
His tenure, which concludes on October 18, 2026, is expected to prioritize high-impact research, particularly in the realm of lymphatic biology—a field where Dr. Mehrara has already established himself as a global authority.
Chronology: The Path to Leadership
The trajectory of Dr. Mehrara’s career reflects a decades-long commitment to clinical science. His rise to the presidency of The PSF is the culmination of years spent in surgical theaters and laboratories alike.
- Early Academic Foundation: Dr. Mehrara’s career was built upon rigorous academic training, culminating in his current role as Professor of Surgery at Weill Cornell Medical College.
- The MSK Tenure: Currently serving as the Chief of the Plastic and Reconstructive Surgery Service at Memorial Sloan Kettering Cancer Center (MSK), he has led some of the most complex reconstructive cases in the world. He also holds the Peter G. Cordeiro Endowed Chair in the Department of Surgery at MSK.
- The NIH Connection: Beyond his clinical responsibilities, Dr. Mehrara’s directorship of the National Institutes of Health (NIH)-funded Lymphatic Biology Laboratory has been a cornerstone of his career. This laboratory serves as a hub for understanding the molecular mechanisms of lymphatic diseases.
- October 12, 2025: Dr. Mehrara officially assumes the presidency of The Plastic Surgery Foundation at Plastic Surgery The Meeting in New Orleans.
- October 2025–October 2026: The term of his presidency, during which he intends to reshape the research landscape for the ASPS.
Supporting Data: The Scope of Influence
To understand the weight of Dr. Mehrara’s leadership, one must examine the breadth of his contribution to surgical literature and clinical practice. He is not merely a surgeon; he is a prolific academic.
The Research Portfolio
Dr. Mehrara has authored more than 400 peer-reviewed publications. This volume of work is significant not only for its quantity but for its impact on clinical guidelines. His research has been instrumental in the surgical and nonsurgical management of cancer-related lymphedema—a condition that affects millions of cancer survivors worldwide.
The Laboratory Impact
His work at the Lymphatic Biology Laboratory at MSK is particularly notable. By securing sustained NIH funding, Dr. Mehrara has ensured that his team can pursue long-term, high-risk, high-reward studies that private practice settings often cannot sustain. This lab serves as a model for how The PSF intends to support future researchers: by providing the resources to tackle the "impossible" questions in regenerative medicine.
Global Reach
Through his involvement with The PSF, Dr. Mehrara oversees a network that facilitates plastic surgery education and humanitarian care across the globe. The Foundation’s commitment to safety and affordability is underscored by data-driven programs that monitor outcomes in international settings, ensuring that high-quality care is not limited to elite medical centers in the United States.
Official Responses: A Vision for the Future
Upon his appointment, Dr. Mehrara expressed a clear and ambitious vision for his tenure. His words emphasize a focus on the next generation of practitioners and the importance of mentorship.
"It’s an honor to lead The PSF, and I look forward to building on its legacy of excellence in plastic surgery research and innovation," Dr. Mehrara stated during his inaugural address in New Orleans. "I am deeply committed to the advancement of scientific discovery and supporting the work of residents, early-career researchers, and emerging innovators."
He further articulated a strategy centered on inclusivity and expansion: "Throughout my presidency, I will champion new ways to strengthen and expand The Foundation’s mission of research and education. We must ensure that our research pipeline is not just productive, but sustainable and accessible to those who are just beginning their careers."
Colleagues within the ASPS have noted that Dr. Mehrara’s appointment is a strategic choice. By placing a researcher who is also a high-volume clinician at the head of the Foundation, the ASPS is signaling a move toward "translational surgery"—the process of moving laboratory discoveries into the operating room as rapidly and safely as possible.
Implications: The Future of Plastic Surgery
The presidency of Dr. Mehrara carries significant implications for the future of the plastic surgery specialty.
Bridging Research and Practice
One of the most pressing challenges in modern medicine is the "bench-to-bedside" lag. Dr. Mehrara’s leadership is expected to shorten this window. By utilizing The PSF’s grants to incentivize clinical trials that incorporate biological markers and lymphatic function studies, he is positioning plastic surgery as a central pillar of oncology care.
The Role of Technology
Under his leadership, The PSF is expected to explore the integration of AI and machine learning into reconstructive planning. Given his background at a premier cancer center like MSK, he is well-positioned to oversee the use of digital modeling in complex tumor resection and subsequent reconstruction.
Addressing Health Inequity
A major goal of the upcoming year is to expand access to safe, effective, and affordable plastic surgery care. This involves not only international aid missions but also addressing the disparities in care within the United States. Dr. Mehrara has hinted that part of his legacy will be the establishment of partnerships that facilitate the standardization of care, ensuring that a patient in a rural setting has access to the same evidence-based reconstructive protocols as a patient in a major academic center.
Mentorship and the Next Generation
Finally, the implications for surgical training are profound. By prioritizing the support of residents and early-career researchers, Dr. Mehrara is effectively "future-proofing" the specialty. He understands that the surgeons of 2035 will need a different skill set than those of 2005—specifically, a deeper literacy in genomics, immunology, and advanced imaging.
Conclusion
As Dr. Babak J. Mehrara steps into this leadership role, the expectations are high, yet the foundation for success is already well-laid. His dual identity as a scientist and a surgeon provides a rare synergy that the plastic surgery community is eager to leverage.
The year ahead will be defined by his commitment to rigorous, NIH-style inquiry and his dedication to the human element of surgical practice. From the laboratories of Memorial Sloan Kettering to the global initiatives of The Plastic Surgery Foundation, Dr. Mehrara’s presidency promises to be a transformative era for a specialty that is, at its core, dedicated to the restoration of form and function. As he noted, the goal is not just to improve surgery, but to improve the lives of the patients who rely on it—a mandate he seems prepared to carry out with precision, compassion, and academic rigor.
About the Author
